About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Spain's Ferrer International Partners With Dr.Reddy's Lab to Launch Somazia in India

by Julia Samuel on May 18, 2015 at 4:37 PM
Font : A-A+

Spain's Ferrer International Partners With Dr.Reddy's Lab to Launch Somazia in India

Dr.Reddy's Laboratories have announced the launch of Somazina, the innovator brand of Citicolin in India. Dr. Reddy's has partnered with Ferrer International S.A., Spain, the global innovator of Citicoline, to make Somazina available in India.

The drug is vital in the management of stroke and has been used for the treatment of post-stroke patients around the world.

Advertisement

Somazina is indicated to improve cognitive function in patients who have suffered from stroke or cerebral infarction, or who have undergone a brain surgery or have suffered from head injuries.

The brand, Citicoline is widely used as a neuro-protectant to help accelerate the recovery from stroke. It is used in both ischemic and haemorrhagic strokes, and provides a compelling option to physicians treating stroke patients.
Advertisement

"Citicoline is safe to use and may have a beneficial effect in stroke patients. Citicoline is the only drug, that in a number of different clinical stroke trials, has had some neuroprotective effect." shared Dr. Atul Prasad, Director & Sr. Consultant, BLK Super specialty hospital, Delhi.

Cerebral Stroke is the third leading cause of deaths in India, as per the Global Burden of Disease Study 2013. "Stroke is a major cause of disability and death in India. There is a pressing need for novel neuroprotective agents which can salvage brain tissue and optimize the functional outcome," said Subhash Kaul, renowned senior neurologist from NIMS, Hyderabad.

Source: Medindia
Advertisement

Advertisement
Advertisement

Latest Drug News

 India's First Urinary Incontinence Drug Launched
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
 New Ray of Hope for Atrial Fibrillation Patients With Kidney Disease
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Anti-viral Drug Bulevirtide Helps Treat Chronic Hepatitis D
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Antiviral Drug Paxlovid Linked to Lower Risk of Hospital Admission
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
Price Cap Move Will Place Eli Lilly Strongly in Insulin Market
Lilly will likely maintain or increase its market share in the insulin space as the average out-of-pocket cost for its insulin products is already below the $35 price cap.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Spain's Ferrer International Partners With Dr.Reddy's Lab to Launch Somazia in India Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests